Intrinsiqq
Park Dental Partners Inc. logoPark Dental Partners Inc.PARK
$18.95-1.33%
Park Dental Partners Inc. logo

Park Dental Partners Inc.

PARK

$18.95

-$0.25 (-1.33%)

⊜ Compare
ProfitabilityUnprofitableGrowthN/ACash FlowThin conversionValuationN/A
What stands out

Operating margin is thin at 0.10%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.

What deserves caution

Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.

Price History

+84.9%

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$118M
EPS-$0.57
P/E-33.42
P/FCF11.77
EV/EBITDA63.23
FCF Yield8.5%
Div. Yield—
Net Debt/FCF3.5x
52-Week Range
$10.25$23.05

Profitability & Returns

Revenue (TTM)

$251M

Net Income (TTM)

-$4M

Op. Margin

-2.81%

ROIC

0.24%

Cash Flow & Balance Sheet

FCF (TTM)

$10M

Op. Cash Flow (TTM)

$18M

Net Debt

$35M

Cash & Equiv.

$25M

Continue Research

Is Park Dental Partners (PARK) overvalued?

Park Dental Partners (PARK) trades around a two-stage DCF intrinsic value of about $22.26 per share, so at $18.95 the stock looks around fair value (17.5% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.

On quality, Park Dental Partners scores 14/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.

Frequently asked

What is Park Dental Partners's fair value?+

Intrinsiqq's two-stage DCF estimates an intrinsic value of about $22.26 per share for PARK, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $16.70. At today's $18.95, that puts the stock about 17.5% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.

Is Park Dental Partners a high-quality business?+

Park Dental Partners scores 14 out of 100 on Intrinsiqq's quality score, a weighted blend of 3 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -2.8% operating margin and a 0.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.

Is Park Dental Partners a good stock to buy right now?+

That depends on valuation and quality together, not either alone. PARK currently trades around its estimated intrinsic value and scores 14/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.

Related stocks: Medical Care Facilities

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.